Xiamen biotech firm's testing reagents meet FDA's emergency use authorization to enter American market
April 8, 2022
Xiamen Boson Biotech Co produced COVID-19 antigen self-test kits that have been approved for emergency use authorization (EUA) by the Food and Drug Administration (FDA) on April 6, marking the company's progress in the American market.
March 23, 2022
On March 21, one million antigen self-testing kits given by Xiamen Boson Biotech Co, a company specializing in in vitro diagnostic kits, were shipped to Hong Kong with the support of the Xiamen municipal bureau of trade.
February 9, 2022
The International Laboratory Accreditation Cooperation granted the medical institution of AmoyDx, an R&D based diagnostic enterprise in Xiamen, Fujian province, ISO 15189 certification.
January 20, 2022
Xiamen companies serve Team China at 2022 Beijing Winter Olympic Games.
January 18, 2022
Xiamen Voke Mold and Plastic Engineering Co, an injection molding company, listed on the Growth Enterprise Market (GEM) on January 11, becoming the first A-share listed company in Xiamen this year.
December 15, 2021
In three newly built plants of a Taiwan-funded industrial park, workers are busy testing the equipment. Before long, their products will enter gyms and fitness centers on the Chinese mainland.
December 10, 2021
Leading global technology company ABB Group first established its agency in Xiamen, Fujian province in 1991, marking the beginning of its expansion and development in the coastal city.
December 6, 2021
Established in 2004 and headquartered in Xiamen Torch Development Zone, NewSound is a national high-tech company specializing in the research, development, production, and sales of hearing aid products.